Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

PML is a direct p53 target that modulates p53 effector functions.

Elisa de Stanchina1, Emmanuelle Querido, Masako Narita

  • 1Cold Spring Harbor Laboratory, 1 Bungtown Road, Cold Spring Harbor, NY 11724, USA.

Molecular Cell
|March 3, 2004
PubMed
Summary

The tumor suppressor p53 (also known as TP53) is regulated by the promyelocytic leukemia gene (PML). PML potentiates p53

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Clinically Integrated Pediatric Patient-Derived Xenograft Program Enables Evaluation of Cohort and Patient-Specific Biology and Therapeutic Strategies.

Cancer research·2026
Same author

<i>SMARCA4, STK11,</i> and <i>KEAP1</i> co-inactivation associates with poor prognosis and upregulation of the TGF-β pathway in lung adenocarcinoma.

bioRxiv : the preprint server for biology·2026
Same author

Distinct ERK and PI3K dependencies mediate a heterogeneous response to RAS(ON) inhibition in KRAS-mutant colorectal cancer.

Cell reports·2026
Same author

Clinicogenomic analysis of <i>EGFR</i>-mutant lung tumors identifies Rb pathway inactivation as a hallmark of squamous transformation.

Science translational medicine·2026
Same author

Hierarchical classification of immune cell transcriptomes at population-scale.

bioRxiv : the preprint server for biology·2026
Same author

Exercise suppresses breast cancer and reprograms the immune tumor microenvironment, cancer cell intrinsic features, and their interaction.

Journal of sport and health science·2026

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cellular Stress Response

Background:

  • The p53 tumor suppressor is a critical regulator of cellular responses to stress, including cell cycle arrest and apoptosis.
  • The promyelocytic leukemia gene (PML) has been previously implicated in modulating p53 activity, potentially acting upstream to enhance p53 target gene transcription.

Purpose of the Study:

  • To elucidate the regulatory relationship between p53 and PML.
  • To investigate the role of PML in mediating p53's tumor suppressor functions.

Main Methods:

  • Analysis of PML as a p53 target gene using reporter assays and in vitro/in vivo binding studies.
  • Assessment of p53-dependent PML induction in response to oncogenes and DNA-damaging agents.
  • Evaluation of cellular senescence and apoptosis in PML-deficient cells following p53 activation.

Related Experiment Videos

Main Results:

  • PML is identified as a direct transcriptional target of p53, with p53 binding sites within the PML gene.
  • p53 is required for PML induction by oncogenes and chemotherapeutics, and PML potentiates p53's antiproliferative effects.
  • PML-deficient cells exhibit impaired senescence and apoptosis upon p53 activation, despite induction of other p53 targets.

Conclusions:

  • PML acts downstream of p53, mediating and amplifying p53's tumor suppressor functions.
  • This study establishes PML as a crucial mediator in the p53 pathway, highlighting a feedback loop in tumor suppression.